Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00206427 · ClinicalTrials.gov registry record · Phase 2
Neoadjuvant GW572016 to Treat Breast Cancer
A Phase 2 study, sponsored by Baylor Breast Care Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 49
- Enrollment target
NCT00206427 is a Phase 2 study that has completed, run by Baylor Breast Care Center. The registered enrollment target is 49 participants.
The verdict
NCT00206427, a Phase 2 study, has completed, sponsored by Baylor Breast Care Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 49 participants
- Enrollment target
Study Summary
We want to learn whether GW572016 is effective in breast cancers that have HER2.
Interventions
- DRUG lapatinib
- DRUG GW572016
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2004-08 |
| Est. Completion | 2012-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00206427
The ClinicalTrials.gov registry entry for NCT00206427 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Breast Care Center, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which lapatinib is the first listed.
NCT00206427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00206427 about?
NCT00206427 is a clinical study titled "Neoadjuvant GW572016 to Treat Breast Cancer". We want to learn whether GW572016 is effective in breast cancers that have HER2.
What is the current status of trial NCT00206427?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2004-08. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00206427?
The interventions under investigation include: lapatinib (DRUG), GW572016 (DRUG).
Who is sponsoring clinical trial NCT00206427?
This trial is sponsored by Baylor Breast Care Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.